Fujieda Y, Doi M, Asaka T, Ota M, Hisada R, Ohnishi N, Kono M, Kameda H, Nakazawa D, Kato M, Amengual O, Takahata M, Yasuda S, Kitagawa Y, Atsumi T
Incidence and risk of antiresorptive agents-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease.
JBMM PMID: 32076874
令和元年度 北海道大学 教育研究総長表彰
アメリカ内分泌学会 Outstanding abstract award 千葉 幸輝先生
令和元年度北海道科学技術奨励賞 中村 昭伸先生
フラテ研究奨励賞 亀田 啓先生
Aika Miya, Akinobu Nakamura, Hideaki Miyoshi, Shigekazu Ukawa, Koshi Nakamura, Takafumi Nakagawa, Yasuo Terauchi, Akiko Tamakoshi, Tatsuya Atsumi
Correlation between serum proinsulin levels and fatty liver: the DOSANCO Health Study
Journal of Diabetes Investigation, in press.
IF: 3.902
Lee WS, Yasuda S, Kono M, Kudo Y, Shimamura S, Kono M, Fujieda Y, Kato M, Oku K, Shimizu T, Onodera T, Iwasaki N and Atsumi T.
MicroRNA-9 Ameliorates Destructive Arthritis through Down-regulation of NF-κB1-RANKL Pathway in Fibroblast-like Synoviocytes Clinical Immunology IF 3.548
Kameda R, Nomoto H, Cho KY, Kawata S, Omori K, Takeuchi J, Nagai S, Kurihara Y, Aoki S, Nakamura A, Atsumi T, Miyoshi H.
Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicenter, prospective, randomized, open-label, blinded endpoint parallel-group comparison study.
BMJ Open. 2020
Nakamura A, Miyoshi H, Kameda H, Yamashita K, Kurihara Y.
Impact of sodium-glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria
Diabetol Metab Syndr. 2020.
Nakamura H, Fujieda Y, Tarumi M, Kitakawa H, Hisada R, Nakagawa I, Noguchi A, Kurita T, Kataoka H, Kasahara H, Amasaki Y, Yokota I,
Atsumi T
Calcineurin Inhibitors for Adult-Onset Still’s Disease: A Multi-Center Epidemiological Study
Clin Exp Rheumatol
IF: 3.238